1. Home
  2. SILO

as of 03-27-2026 4:00pm EST

$0.34
$0.04
-10.29%
Stocks Consumer Discretionary Apparel Nasdaq

SILO Pharma Inc is a developmental stage biopharmaceutical company developing novel therapeutics that address underserved conditions including stress-induced psychiatric disorders, chronic pain conditions, and central nervous system (CNS) diseases. It focuses on developing traditional therapies and psychedelic treatments in novel formulations and drug delivery systems. The company's primary program, SPC-15, is an intranasal treatment targeting PTSD and stress-induced anxiety disorders.

Founded: 2010 Country:
United States
United States
Employees: N/A City: SARASOTA
Market Cap: 4.6M IPO Year: 2011
Target Price: N/A AVG Volume (30 days): 212.1K
Analyst Decision: N/A Number of Analysts: N/A
Dividend Yield:
N/A
Dividend Payout Frequency: annual
EPS: -0.50 EPS Growth: 0.83
52 Week Low/High: $0.22 - $1.23 Next Earning Date: 05-08-2026
Revenue: $72,102 Revenue Growth: N/A
Revenue Growth (this year): 1.86% Revenue Growth (next year): N/A
P/E Ratio: -0.76 Index: N/A
Free Cash Flow: N/A FCF Growth: N/A

Share on Social Networks: